PG
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Facteurs de risque et prophylaxie de la pneumonie à Pneumocystis jirovecii chez les patients non VIH | Revue médicale suisse | 2018 | 459 | 147 | |||
A 64-Year-Old Woman with Chest Pain, Limb Weakness, and Endometrial Cancer | Case reports in rheumatology | 2017 | 444 | 2 | |||
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study | Joint, Bone, Spine | 2016 | 507 | 0 | |||
Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome | Joint bone spine | 2015 | 567 | 2 | |||
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial | Arthritis research & therapy | 2014 | 657 | 186 | |||
Rheumatoid meningitis occurring during adalimumab and methotrexate treatment | Joint bone spine | 2012 | 622 | 1 | |||
Large paralabral cyst in the axilla | Joint bone spine | 2012 | 585 | 0 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 992 | 573 | |||
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 837 | 8 | |||
EULAR recommendations for calcium pyrophosphate deposition. Part II: management | Annals of the rheumatic diseases | 2011 | 643 | 0 | |||
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis | Annals of the rheumatic diseases | 2011 | 743 | 1 | |||
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | 2010 | 830 | 3 | |||
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies | Schweizerische medizinische Wochenschrift | 2009 | 597 | 259 | |||
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice | Arthritis research & therapy | 2009 | 765 | 770 | |||
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis | Clinical and Experimental Rheumatology | 2009 | 521 | 0 | |||
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure | Joint bone spine | 2009 | 528 | 0 | |||
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation | Arthritis research & therapy | 2009 | 590 | 211 | |||
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc | Spine | 2008 | 635 | 0 | |||
Benefits of a programme taking advantage of patient-instructors to teach and assess musculoskeletal skills in medical students | Annals of the rheumatic diseases | 2006 | 617 | 289 | |||
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes | Arthritis research & therapy | 2006 | 543 | 256 | |||
La dermatomyosite juvénile : une maladie différente de la forme adulte ? | Médecine et hygiène | 2001 | 508 | 9 | |||
Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone | Matrix biology | 1999 | 557 | 0 |